Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Verisk Buys PowerAdvocate To Boost Energy Sector Presence

Published 11/30/2017, 08:34 PM
Updated 07/09/2023, 06:31 AM
SPGI
-
FDS
-
VRSK
-
TRU
-

Verisk Analytics, Inc. (NASDAQ:VRSK) recently inked an agreement to acquire PowerAdvocate for $200 million in order to augment its presence in the energy sector. PowerAdvocate internationally caters to the energy sector by providing market, cost intelligence and supply chain solutions, mitigating risk and optimizing total cost of production.

PowerAdvocate offers key insights into customer’s cost-saving opportunities by analyzing spend and cost data obtained from millions of transactions across thousands of services, materials and equipment categories in the energy industry. With its wide range of proprietary data, this enables companies to bring transparency in the market and ensure that capital is utilized efficiently.

How the Deal will Benefit the Companies

As Verisk draws on unique data sets to provide predictive analytics and decision support solutions to customers in rating, it is expected to benefit immensely from this acquisition. The company, with its decision support solutions, has facilitated its customers to take informed decisions with greater precision, efficiency and discipline about various risks involved in business. This buyout will bring more enterprises in the energy sector within Verisk’s reach by adding PowerAdvocate’s spend data and cost models.

The deal will add to Verisk’s existing pool of customers, giving it greater access to the global markets. Verisk with PowerAdvocate’s proprietary data set, encompassing $2.7 trillion of spending data and machine-learned methods, will provide customers with unique insight to increase profitability. Verisk’s revenues are likely to increase significantly as a result of this acquisition, providing greater market strength.

PowerAdvocate’s 2017 revenues, which are expected to be around $36 million, are likely to increase at much higher rate than Verisk’s historical average organic annual growth rate of 7-8%. Its estimated EBITDA is expected to be $11 million. Additionally, Verisk is anticipating an attractive return excess of its cost of capital from this acquisition.

Verisk has underperformed the industry in a year with a gain of 17.3% compared with a rally of 26.6% for the latter. With such strategic acquisitions, the company expects to gradually improve its future performance.



Zacks Rank & Stocks to Consider

Verisk currently has the Zacks Rank # 3 (Hold). Some better-ranked stocks in the space are FactSet Research Systems Inc. (NYSE:FDS) , S&P Global Inc. (NYSE:SPGI) and TransUnion (NYSE:TRU) each carrying Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

FactSet Research has a long-term earnings growth expectation of 10.8 %. It topped earnings estimates in each of the trailing four quarters with an average positive surprise of 1.14%.

S&P Global has a long-term earnings growth expectation of 12.5%. It topped earnings estimates in each of the trailing four quarters with an average positive surprise of 11.11%.

TransUnion has a long-term earnings growth expectation of 10.0%. It topped earnings estimates in each of the trailing four quarters with an average positive surprise of 10.25%.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



FactSet Research Systems Inc. (FDS): Free Stock Analysis Report

Verisk Analytics, Inc. (VRSK): Free Stock Analysis Report

TransUnion (TRU): Free Stock Analysis Report

S&P Global Inc. (SPGI): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.